CNO Financial vs Globe Life
CNO and GL side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CNO and GL compare
Globe Life is the larger company, worth 2.3 times as much as CNO Financial ($12.3B against $5.3B).
On earnings, Globe Life is cheaper: it trades at 10.7× trailing earnings, against 13.1× for CNO Financial.
Globe Life grew revenue faster over the last twelve months (5.6% versus 2.3% for CNO Financial).
Globe Life keeps more of each dollar of sales as profit, with a net margin of 18.9% compared with 9.2% at CNO Financial.
Both pay dividends: CNO Financial yields 1.2% and Globe Life 0.79%.
Globe Life scores higher on the StockData Score (13 against 9 for CNO Financial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CNO | GL |
|---|---|---|
| Size and price | ||
| Market cap | $5.3B | $12.3B |
| Share price | $57.44 | $160.11 |
| Change, 1 year | 40.1% | 21.0% |
| Change, 5 years | 140% | 73.2% |
| Beta (5Y) | 0.87 | 0.55 |
| Employees | 3,300 | 3,695 |
| StockData Score | ||
| Total score | 9 | 13 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 4 | 6 (better) |
| Health score | 0 | 1 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 13.1× | 10.7× (better) |
| P/S | 1.2× (better) | 2.0× |
| P/B | 2.3× | 1.9× (better) |
| EV/EBITDA | 3.9× | – |
| P/FCF | – | 9.2× |
| PEG | – | 0.67 |
| FCF yield | – | 10.8% |
| Fair value | $57.41 | $158.48 |
| Margin of safety | −0.04% (better) | −1.0% |
| Growth | ||
| Revenue growth (TTM) | 2.3% | 5.6% (better) |
| Revenue growth, 5Y average | 3.3% | 4.8% (better) |
| Net income growth (TTM) | 30.8% (better) | 3.1% |
| EPS growth (TTM) | 41.3% (better) | 8.3% |
| EPS growth, 5Y average | 1.7% | 15.6% (better) |
| Profitability | ||
| Operating margin | 14.8% | – |
| Net margin | 9.2% | 18.9% (better) |
| FCF margin | – | 21.3% |
| Return on equity | 16.9% | 19.3% (better) |
| Return on invested capital | 45.4% | – |
| Financial health | ||
| Debt / equity | – | 0.45 |
| Interest coverage | 3.1× | – |
| Altman Z-score | 0.35 | 0.94 (better) |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.2% (better) | 0.79% |
| Payout ratio | 15.9% | 7.9% |
| Years of dividend growth | 13 | 16 (better) |
| Dividend growth, 5Y average | 7.3% | 7.6% (better) |
| Buyback yield | 4.5% | 6.3% (better) |
| Shareholder yield | 5.8% | 7.1% (better) |
| Ownership | ||
| Held by institutions | 95.8% | 84.7% |
| Held by insiders | 3.4% | 0.85% |
| Insider net buying, 12 months | −$18.4M (better) | −$82.9M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.9% | 2.9% |
Go deeper
- CNO stock overview
- CNO income statement
- CNO valuation and score
- GL stock overview
- GL income statement
- GL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.